Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin - 24/08/11
Doi : 10.1016/S1470-2045(04)01428-7
Andrew L Feldman, Dr a, ⁎ 
: Clinical Fellow, Caterina Minniti b : Assistant Professors of Paediatrics, Mariarita Santi b : Assistant Professors of Paediatrics, James R Downing c : Member and Chairman, Mark Raffeld a : Staff Physician, Elaine S Jaffe a : Chief of Hematopathology Section
: Clinical Fellow, Caterina Minniti b : Assistant Professors of Paediatrics, Mariarita Santi b : Assistant Professors of Paediatrics, James R Downing c : Member and Chairman, Mark Raffeld a : Staff Physician, Elaine S Jaffe a : Chief of Hematopathology Section a Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA
b George Washington University, Washington, DC, USA and Attending Physicians in the Departments of Hematology–Oncology and Pathology, respectively, at the Children’s National Medical Center, Washington, DC, USA
c Department of Pathology, St Jude Children’s Research Hospital, Memphis, TN, USA
* Correspondence: Dr Andrew L Feldman, Laboratory of Pathology, National Cancer Institute, Building 10, Room 2A33, 10 Center Drive, Bethesda, MD 20892, USA. Tel: +1 (301) 5942945. Fax: +1 (301) 4809488
© 2004
Elsevier Ltd. Tous droits réservés.
Vol 5 - N° 4
P. 248-250 - avril 2004 Retour au numéro
Article précédent
- Penile carcinoma: a challenge for the developing World
- Sanjeev Misra, Arun Chaturvedi, Naresh C Misra
- Adjuvant interferon alfa treatment for patients with malignant melanoma stimulates transporter proteins associated with antigen processing and proteasome activator 28
- Faris Abuzahra, Ruth Heise, Sylvia Joussen, Alexandra Dreuw, Hans Merk, Gabriele Zwadlo-Klarwasser, Jens M Baron
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?